Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ketorolac intranasal - Zyla Life Sciences

Drug Profile

Ketorolac intranasal - Zyla Life Sciences

Alternative Names: Ketorolac trometamol intranasal; Ketorolac trometamol nasal spray; Ketorolac tromethamine intranasal; Ketorolac tromethamine nasal spray; ROX-828; ROX-888; Sprix

Latest Information Update: 27 Aug 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ROXRO PHARMA
  • Developer American Regent; OraPharma; ROXRO PHARMA; Zyla Life Sciences
  • Class 2 ring heterocyclic compounds; Carboxylic acids; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Acute pain
  • No development reported Postoperative pain
  • Discontinued Migraine

Most Recent Events

  • 27 Aug 2019 No development reported - Phase-III for Postoperative pain (In adolescents) in USA (Intranasal)
  • 27 Aug 2019 No development reported - Phase-III for Postoperative pain (In children, In infants, In neonates) in Poland, USA (Intranasal)
  • 02 Jan 2019 Luitpold Pharmaceuticals is now called American Regent
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top